Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment

DM Niyazov, SG Kahler, RE Frye - Molecular syndromology, 2016 - karger.com
… The following case report illustrates our approach to a patient with SMD [Niyazov and Africk,
… Skladal D, Halliday J, Thorburn D: Minimum birth prevalence of mitochondrial respiratory …

[HTML][HTML] Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder

S Rose, DM Niyazov, DA Rossignol… - Molecular diagnosis & …, 2018 - Springer
Autism spectrum disorder (ASD) affects ~ 2% of children in the United States. The etiology
of ASD likely involves environmental factors triggering physiological abnormalities in …

A copy number variation morbidity map of developmental delay

…, H Abdel-Hamid, P Bader, E McCracken, D Niyazov… - Nature …, 2011 - nature.com
To understand the genetic heterogeneity underlying developmental delay, we compared
copy number variants (CNVs) in 15,767 children with intellectual disability and various …

[HTML][HTML] Phenotypic heterogeneity of genomic disorders and rare copy-number variants

…, DM Niyazov, LF Escobar, D El-Khechen… - … England Journal of …, 2012 - Mass Medical Soc
Background Some copy-number variants are associated with genomic disorders with
extreme phenotypic heterogeneity. The cause of this variation is unknown, which presents …

[PDF][PDF] Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss

…, J Juusola, K Retterer, C Joshi, D Niyazov… - The American Journal of …, 2015 - cell.com
Using whole-exome sequencing, we have identified in ten families 14 individuals with
microcephaly, developmental delay, intellectual disability, hypotonia, spasticity, seizures, …

High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients …

…, AS Aylsworth, JS Bamforth, D Babu, DM Niyazov… - Human genetics, 2012 - Springer
Microdeletions of 1q43q44 result in a recognizable clinical disorder characterized by moderate
to severe intellectual disability (ID) with limited or no expressive speech, characteristic …

Investigation of NRXN1 deletions: Clinical and molecular characterization

…, LM Randolph, D Niyazov… - American Journal of …, 2013 - Wiley Online Library
Deletions at 2p16.3 involving exons of NRXN1 are associated with susceptibility for autism
and schizophrenia, and similar deletions have been identified in individuals with …

[PDF][PDF] Mutations impairing GSK3-mediated MAF phosphorylation cause cataract, deafness, intellectual disability, seizures, and a down syndrome-like facies

…, MT Fiorenza, C Boitani, N Philip, D Niyazov… - The American Journal of …, 2015 - cell.com
… (D) Transactivation assays were performed in COS1 cells transiently cotransfected with the
IL4 promoter cloned into pGL3 vector reporter construct (kindly provided by Michael Lohoff, …

[HTML][HTML] The expanding clinical phenotype of Bosch-Boonstra-Schaaf optic atrophy syndrome: 20 new cases and possible genotype–phenotype correlations

…, E Malkin, WK Chung, D Niyazov… - Genetics in …, 2016 - nature.com
Purpose: Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) is an autosomal-dominant
disorder characterized by optic atrophy and intellectual disability caused by loss-of-…

Diagnosis of endolymphatic hydrops in vivo with magnetic resonance imaging

DM Niyazov, JC Andrews, D Strelioff, S Sinha… - Otology & …, 2001 - journals.lww.com
Background Endolymphatic hydrops is believed to be associated with a number of ear
diseases, including Ménière's disease. Although the pathologic changes of overaccumulation of …